Billiald P, Slater AS, Welin M, Clark JC, Loyau S, Pugnière M, Jiacomini IG, Rose N, Lebozec K, Toledano E, François D, Watson SP, Jandrot-Perrus M.

Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition.

Blood Adv. 2023 Apr 11;7(7):1258-1268. doi: 10.1182/bloodadvances.2022007863. PubMed PMID: 36375047

Remerciement

Pour tous travaux utilisant des équipements du PPM, merci d'utiliser la phrase type de remerciements : "

Mass spectrometry experiments were carried out using the facilities of the Montpellier Proteomics Platform (PPM, BioCampus Montpellier), a member of the national Proteomics French Infrastructure (ProFI UAR 2048) supported by the French National Research Agency (ANR-24-INBS-0015, Investments for the future F2030).

Aller au haut